Healthcare
Tuesday, August 9, 2016
Mylan 2nd quarter profit rises; 2016 EPS forecast unchanged
Aug 9 (Reuters) - Mylan NV on Tuesday reported
higher second quarter profit on increased demand for its
generic medicines and specialty drugs.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment